{"id":12890,"date":"2023-04-12T04:30:00","date_gmt":"2023-04-12T08:30:00","guid":{"rendered":"https:\/\/dbv-technologies.com\/press_releases\/dbv-technologies-annonce-les-resultats-de-son-assemblee-generale-ordinaire-et-extraordinaire-2023\/"},"modified":"2023-04-21T12:51:18","modified_gmt":"2023-04-21T16:51:18","slug":"dbv-technologies-annonce-les-resultats-de-son-assemblee-generale-ordinaire-et-extraordinaire-2023","status":"publish","type":"press_releases","link":"https:\/\/dbv-technologies.com\/fr\/press_releases\/dbv-technologies-annonce-les-resultats-de-son-assemblee-generale-ordinaire-et-extraordinaire-2023\/","title":{"rendered":"DBV Technologies annonce les r\u00e9sultats de son Assembl\u00e9e g\u00e9n\u00e9rale ordinaire et extraordinaire 2023"},"content":{"rendered":"<div class=\"pr-date-globe\">April 12, 2023 16:30 ET<\/div>\n<p>                            <!-- <span>Name:DistributionId<\/span>   <span>Value:1000803607<\/span> -->                            <!-- <span>Name:EnableQuoteCarouselOnPnr<\/span>   <span>Value:False<\/span> -->                            <!-- <span>Name:IcbCode<\/span>   <span>Value:4573<\/span> -->                            <!-- <span>Name:CustomerId<\/span>   <span>Value:1011152<\/span> -->                            <!-- <span>Name:HasMediaSnippet<\/span>   <span>Value:false<\/span> -->                            <!-- <span>Name:AnalyticsTrackingId<\/span>   <span>Value:2cd1feb4-395d-4e2b-9851-d7ffbd1766a3<\/span> --><\/p>\n<p align=\"right\">Montrouge, France, le 12 avril (22h30 CEST) 2023<\/p>\n<p align=\"justify\"><strong>DBV <\/strong><strong>Technologies annonce <\/strong><strong>l<\/strong><strong>es<\/strong><strong> r\u00e9sultats <\/strong><strong>de son<\/strong><strong> Assembl\u00e9e g\u00e9n\u00e9rale ordinaire et extraordinaire<\/strong> <strong>202<\/strong><strong>3<\/strong><\/p>\n<p align=\"justify\"><strong>Toutes les r\u00e9solutions propos\u00e9es \u00e0 l\u2019Assembl\u00e9e ont \u00e9t\u00e9 adopt\u00e9es<\/strong><\/p>\n<p align=\"justify\">DBV Technologies (Euronext : DBV \u2013 ISIN : FR0010417345 \u2013 Nasdaq : DBVT), soci\u00e9t\u00e9 biopharmaceutique fran\u00e7aise au stade clinique, a tenu aujourd\u2019hui son Assembl\u00e9e G\u00e9n\u00e9rale Ordinaire et Extraordinaire. L\u2019Assembl\u00e9e G\u00e9n\u00e9rale de DBV Technologies s\u2019est d\u00e9roul\u00e9e au si\u00e8ge social de la Soci\u00e9t\u00e9, sous la pr\u00e9sidence de Michel de Rosen, Pr\u00e9sident du Conseil d\u2019administration de DBV Technologies. <\/p>\n<p align=\"justify\">Toutes les r\u00e9solutions pr\u00e9sent\u00e9es par le Conseil d\u2019administration ont \u00e9t\u00e9 adopt\u00e9es. Ces r\u00e9solutions et leurs r\u00e9sultats sont accessibles sur le site internet de la Soci\u00e9t\u00e9, dans la rubrique Investisseurs\/Assembl\u00e9es g\u00e9n\u00e9rales annuelles&nbsp;: <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=JHRLorPwbHnDaHo264gcVWpcV41HBvtNosiS1yyZ2mpi1HkdaQvuXN3LrMqNhOLBTRggvMf3sP-VugSHX8R-zuNDTnCzQZH-sgd__eexnwHqiC1p-vx8uoKjok4otpFnarOXOkuHTsxvZM6su76NOvTLg2tmrwCYA8adEqk71lE2kmU_0U6Ta4CI6kgEPD5EV00HvUtwYhvhScEnKs2jrqF0YMwZPRjG-z86YSenqNI=\" rel=\"nofollow noopener\" target=\"_blank\" title=\"\">https:\/\/www.dbv-technologies.com\/fr\/events\/2023-annual-general-meeting\/<\/a>. <\/p>\n<p align=\"justify\"><strong>A propos de DBV Technologies&nbsp;<\/strong><br \/>DBV&nbsp;Technologies d\u00e9veloppe Viaskin\u2122, une plateforme technologique exclusive exp\u00e9rimentale avec de larges applications potentielles en immunoth\u00e9rapie. Viaskin est bas\u00e9 sur l\u2019immunoth\u00e9rapie \u00e9picutan\u00e9e, ou EPIT\u2122, et constitue la m\u00e9thode de DBV&nbsp;Technologies pour d\u00e9livrer des compos\u00e9s biologiquement actifs au syst\u00e8me immunitaire \u00e0 travers la peau intacte. Avec cette nouvelle classe de produits candidats non invasifs, la Soci\u00e9t\u00e9 vise \u00e0 transformer en toute s\u00e9curit\u00e9 le traitement des patients souffrant d\u2019allergies alimentaires. Les programmes de DBV&nbsp;Technologies sur les allergies alimentaires comprennent des essais cliniques en cours sur Viaskin Peanut. Le si\u00e8ge mondial de DBV&nbsp;Technologies est situ\u00e9 \u00e0 Montrouge, en France, et ses op\u00e9rations nord-am\u00e9ricaines sont bas\u00e9es \u00e0 Basking Ridge, NJ. Les actions ordinaires de la Soci\u00e9t\u00e9 sont n\u00e9goci\u00e9es sur le segment&nbsp;B d\u2019Euronext Paris (symbole&nbsp;: DBV, code ISIN&nbsp;: FR0010417345) et les ADS de la Soci\u00e9t\u00e9 (chacun repr\u00e9sentant une demi-action ordinaire) sont n\u00e9goci\u00e9s sur le Nasdaq Global Select Market (symbole&nbsp;: DBVT).<\/p>\n<p align=\"justify\"><strong>Contact investisseurs <\/strong><br \/>Anne&nbsp;Pollak<br \/>DBV&nbsp;Technologies<br \/>+1&nbsp;857-529-2363<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=_UT7FVDoCCGwGYXS5T0kMpNPYczKfyimchmqHQs4TnvcZwQQFthc3M82BLoY7NQIiUdWXO-Zp2Cf3mJq3j8UoDNjj_puk8Mm2NiuQ8RA3qJurtZN3TvioUcW68ZyZ7Mb\" rel=\"nofollow noopener\" target=\"_blank\" title=\"\"><u>anne.pollak@dbv-technologies.com<\/u><\/a><\/p>\n<p align=\"justify\"><strong>Contact m\u00e9dia<\/strong><br \/>Angela&nbsp;Marcucci<br \/>DBV&nbsp;Technologies<br \/>+1&nbsp;646-842-2393<\/p>\n<p align=\"justify\"><u>angela.marcucci@dbv-technologies.com<\/u><\/p>\n<\/p>\n<p id=\"gnw_attachments_section-header\">    <strong>Pi\u00e8ce jointe<\/strong><\/p>\n<ul id=\"gnw_attachments_section-items\">\n<li>        <a target=\"_blank\" href=\"https:\/\/www.globenewswire.com\/Tracker?data=ktTrus9SAvvaD7bbIeUGlUFABWHAAHlMiaIeMBGKqGEeR7-vM-kQvGW7qC14OfOt4h7enT5sZFo6QPkbBTCNt_pJN7hVIOdH5surOWK3hksJ8zdmwAf9KTKMIk3_i8E0NCrqT7jxTHl6_SQMY6CjXDX8wA-ZZtANFEBL1rpn0zI=\" title=\"version PDF\" rel=\"nofollow noopener\">version PDF<\/a>      <\/li>\n<\/ul>\n<p><img decoding=\"async\" data-src=\"https:\/\/ml-eu.globenewswire.com\/media\/MmNkMWZlYjQtMzk1ZC00ZTJiLTk4NTEtZDdmZmJkMTc2NmEzLTEwMTExNTI=\/tiny\/DBV-Technologies-S-A-.png\" referrerpolicy=\"no-referrer-when-downgrade\" src=\"data:image\/svg+xml;base64,PHN2ZyB3aWR0aD0iMSIgaGVpZ2h0PSIxIiB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciPjwvc3ZnPg==\" class=\"lazyload\">        <\/p>\n","protected":false},"featured_media":0,"template":"","meta":{"_acf_changed":false,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","ast-disable-related-posts":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"wds_primary_press_release_type":0,"footnotes":""},"press_release_type":[45],"class_list":["post-12890","press_releases","type-press_releases","status-publish","hentry","press_release_type-agm-document"],"acf":[],"_links":{"self":[{"href":"https:\/\/dbv-technologies.com\/fr\/wp-json\/wp\/v2\/press_releases\/12890","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/dbv-technologies.com\/fr\/wp-json\/wp\/v2\/press_releases"}],"about":[{"href":"https:\/\/dbv-technologies.com\/fr\/wp-json\/wp\/v2\/types\/press_releases"}],"version-history":[{"count":0,"href":"https:\/\/dbv-technologies.com\/fr\/wp-json\/wp\/v2\/press_releases\/12890\/revisions"}],"wp:attachment":[{"href":"https:\/\/dbv-technologies.com\/fr\/wp-json\/wp\/v2\/media?parent=12890"}],"wp:term":[{"taxonomy":"press_release_type","embeddable":true,"href":"https:\/\/dbv-technologies.com\/fr\/wp-json\/wp\/v2\/press_release_type?post=12890"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}